Protagonist Therapeutics CEO Dinesh V. Patel disposes of common shares worth USD 18.25 million
Reuters2026/09/11 01:18- Protagonist Therapeutics President, CEO, director Dinesh V. Patel filed a Form 4 reporting option exercises with same-day share sales on Sept. 8-10.
- Sold 125,000 shares for about $18.25 million, at weighted average prices of $145.87, $146.18, $144.1.
- Exercised options for 125,000 shares at $21.58 per share.
- Directly owned 522,968 shares following the transactions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"The Big Short" Burry holds coins to cope with turbulent times: reduced portfolio risk exposure and closed December expiry Nvidia and Palantir put options.
On Wednesday, Burry stated that he is reducing risk across all positions and has closed out put options on Nvidia (NVDA.US) and Palantir (PLTR.US) expiring in December 2026, without rolling them over.
Singapore Index Fund NAV per unit stands at S$ 5.35 as of Sept. 10, 2026
Anabatic Technologies issues correction to August securities holders registration report
MSIG Life Indonesia releases transcript of 2026 incidental public expose Q&A
Crypto prices
More
